CAMX:STO
Camurus AB
SEK 743.00
arrow_upward
+1.85%(+13.50) 1D
Nob 18, 10:51:37 AM GMT+1 · SEK
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa CAMX...
Buksan
SEK 728.50
Mataas
SEK 748.00
Mababa
SEK 728.50
Mkt. cap
44.81B
Avg. na dami
102.54K
Dami
31.22K
Mataas nang 52-wk
SEK 750.00
Mababa nang 52-wk
SEK 430.80
Mga natitirang share
60.56M
Bilang ng mga empleyado
323
Buksan
SEK 728.50
Mataas
SEK 748.00
Mababa
SEK 728.50
Mkt. cap
44.81B
Avg. na dami
102.54K
Dami
31.22K
Mataas nang 52-wk
SEK 750.00
Mababa nang 52-wk
SEK 430.80
Mga natitirang share
60.56M
Bilang ng mga empleyado
323
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Investing.com Canada
·
10 minuto ang nakalipas
Camurus at Jefferies Global Healthcare Conference: growth and catalysts By Investing.com
TradingView
·
4 oras ang nakalipas
CAMX: Commercial growth and late-stage pipeline progress support the 2026 outlook
Profile
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
Tungkol sa Camurus AB
CEOFredrik Tiberg
Mga Empleyado323
Itinatag1991
Headquarters-
SektorHealth Care
Industriya-
Websitecamurus.com